GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Pure Biologics SA (STU:PQB) » Definitions » Dividend-Payout-to-FFO

Pure Biologics (STU:PQB) Dividend-Payout-to-FFO


View and export this data going back to 2018. Start your Free Trial

What is Pure Biologics Dividend-Payout-to-FFO?

Dividend-Payout-to-FFO only applies to REITs.


Pure Biologics Business Description

Traded in Other Exchanges
Address
ul. Dunska 11, Wroclaw, POL, 54-427
Pure Biologics SA is a Poland based biopharmaceutical company. It invests in the development of new, innovative (non-generic or biosimilar) biological drugs, medical and diagnostic products. It is mainly engaged in the research and development of the biologically active molecule in the drug development process. It specializes in the production and analysis of recombinant proteins and antibodies, contract studies of early product development phases, protein engineering, protein formulation, genomic sequencing, proteomics analysis and bioinformatics. Its projects include cancer immunotherapy, therapy of neurodegenerative diseases, diagnosis of tumors, and other partner projects.